Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity
- 18 March 2022
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 131, 155181
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 35 references indexed in Scilit:
- Metabolites as regulators of insulin sensitivity and metabolismNature Reviews Molecular Cell Biology, 2018
- Structure-function relationships in pulmonary surfactant membranes: From biophysics to therapyBiochimica et Biophysica Acta (BBA) - Biomembranes, 2014
- Myristate is selectively incorporated into surfactant and decreases dipalmitoylphosphatidylcholine without functional impairmentAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Current perspectives in pulmonary surfactant — Inhibition, enhancement and evaluationBiochimica et Biophysica Acta (BBA) - Biomembranes, 2008
- Lipid rafts are involved in SARS-CoV entry into Vero E6 cellsBiochemical and Biophysical Research Communications, 2008
- Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycleMicrobes and Infection, 2007
- Lipidomics of cellular and secreted phospholipids from differentiated human fetal type II alveolar epithelial cellsJournal of Lipid Research, 2006
- Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2004
- Lung surfactant in subacute pulmonary diseaseRespiratory Research, 2002
- Pulmonary surfactant in health and human lung diseases: state of the artEuropean Respiratory Journal, 1999